SCHEMBL9516974

SCHEMBL9516974

O=CC(c1ccc(Cl)cc1)S(=O)(=O)NC(=O)c1ccc(CO)nc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 3/20 0.44
P4HTM Q9NXG6 3/20 0.39
MEN1 O00255 1/20 0.37
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
KMT2A Q03164 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.37
CASP3 P42574 6/20 0.37
FLT1 P17948 1/20 0.36
FLT4 P35916 1/20 0.36
KDR P35968 1/20 0.36
PTGS1 P23219 3/20 0.36
PTGS2 P35354 3/20 0.36
MAP4K4 O95819 1/20 0.35
VNN1 O95497 1/20 0.35
HDAC3 O15379 2/20 0.34
HDAC1 Q13547 2/20 0.34
HDAC2 Q92769 2/20 0.34
HDAC6 Q9UBN7 2/20 0.34
HDAC4 P56524 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9515748 0.91 P4HTM (0.39) EGFRP4HTMMEN1NPC1RAB9A
SCHEMBL9518019 0.89 MEN1 (0.39) P4HTMMEN1NPC1RAB9AKMT2A
SCHEMBL9517937 0.86 EGFR (0.40) EGFRP4HTMNPC1RAB9ACASP3
SCHEMBL9515768 0.86 HIF1A (0.40) P4HTMMEN1NPC1RAB9AKMT2A
SCHEMBL9517259 0.86 EGFR (0.39) EGFRP4HTMCASP3FLT1FLT4
SCHEMBL9519668 0.85 EGFR (0.42) EGFRP4HTMMEN1NPC1RAB9A
SCHEMBL9516883 0.83 MMP1 (0.39) P4HTMKMT2A
SCHEMBL9515729 0.83 BCL2L1 (0.40) EGFRP4HTMMEN1NPC1RAB9A
SCHEMBL9515891 0.83 EGFR (0.41) EGFRP4HTMMEN1NPC1RAB9A
SCHEMBL9517025 0.81 CASP3 (0.39) P4HTMMEN1NPC1RAB9AKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0567997-A1 4- or 5-(sulf)imido- and (sulfon)amidopyridines and their pyridine-N-oxides, process for their preparation and their use as pharmaceutical HOECHST AKTIENGESELLSCHAFT (DE) 1993-11-03 EP disclosed